Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Network Comparison Type Value Type Rank Filtered Interaction Map green red network_comparison description
Results: HTML CSV LaTeX Showing element 1 to 50 of 3228 in total 
Network Comparison Type: Divided
Value Type: Measured
Filtered: 1
Interaction Map: High confidence

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
description\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
2394.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
450.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5.31521\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
rho-related btb domain-containing protein 2 (deleted in breast cancer 2 gene protein) (p83). [source:swissprot;acc:q9byz6]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
698.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
2597.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3.71868\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
homeobox protein hlx1 (homeobox protein hb24). [source:swissprot;acc:q14774]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
4\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
hbs1-like. [source:refseq;acc:nm\_006620]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
5\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
339.5\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
6\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
junctophilin 2 (junctophilin type 2) (jp-2). [source:swissprot;acc:q9br39]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
7\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
8\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
db83 protein. [source:swissprot;acc:p57088]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
9\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
398.5\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
10\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
11\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
dab2 interacting protein; ngap-like protein; doc-2/dab2 interactive protein. [source:refseq;acc:nm\_032552]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
12\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 4. [source:refseq;acc:nm\_030627]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 3. [source:refseq;acc:nm\_014912]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
871\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
2671\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
xpa binding protein 1; mbd2 interactor protein; putative atp(gtp)-binding protein. [source:refseq;acc:nm\_007266]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
460\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.96739\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
dgcr14 protein (digeorge syndrome critical region 14) (es2 protein). [source:swissprot;acc:q96df8]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
677.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1894.39\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
699.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.7072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2108.52\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
950.561\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.21818\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
892.67\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1833.01\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2.0534\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-7 subunit. [source:swissprot;acc:o60262]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
26\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-12 subunit. [source:swissprot;acc:q9ubi6]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
27\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
895.134\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.04922\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-4 subunit. [source:swissprot;acc:p50150]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
895.194\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.04912\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-3 subunit. [source:swissprot;acc:p29798]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
29\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
895.507\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.04858\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-8 subunit (gamma-9). [source:swissprot;acc:q9uk08]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
895.633\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.04837\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 subunit. [source:swissprot;acc:p30670]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
31\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
895.697\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.04827\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-10 subunit. [source:swissprot;acc:p50151]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
32\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
895.893\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.04793\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 like subunit. [source:swissprot;acc:q9y3k8]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
896.972\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1835.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.04611\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-11 subunit. [source:swissprot;acc:p50152]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
907.546\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1836.71\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.02382\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(y), alpha subunit (alpha-11). [source:swissprot;acc:p29992]\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
35\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
907.564\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
2.02378\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(q), alpha subunit. [source:swissprot;acc:p50148]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
36\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
907.741\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1836.76\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.02344\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(z), alpha subunit (g(x) alpha chain) (gz-alpha). [source:swissprot;acc:p19086]\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
37\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
907.763\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
2.02339\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
38\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
907.774\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
2.02337\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-2 subunit (transducin alpha-2 chain). [source:swissprot;acc:p19087]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
39\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
907.903\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1836.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.02312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
40\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
907.978\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1836.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2.02297\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-1 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04898]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
41\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(k), alpha subunit (g(i) alpha-3). [source:swissprot;acc:p08754]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
42\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
958.237\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1857.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.93827\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 5 (transducin beta chain 5). [source:swissprot;acc:o14775]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
43\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1027.36\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1881.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.83093\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 3 (transducin beta chain 3). [source:swissprot;acc:p16520]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1057.39\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1931.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.82652\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 1 (transducin beta chain 1). [source:swissprot;acc:p04901]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
45\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1056.02\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1926.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.82448\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 4 (transducin beta chain 4). [source:swissprot;acc:q9hav0]\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
46\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
779.167\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
neurogenic differentiation factor 2 (neurod2). [source:swissprot;acc:q15784]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
47\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
chromodomain helicase-dna-binding protein 3 (chd-3) (mi-2 autoantigen 240 kda protein) (mi2-alpha). [source:swissprot;acc:q12873]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
48\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
doc-1 related protein (doc-1r). [source:swissprot;acc:o75956]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
49\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
neurogenic differentiation factor 6 (neurod6) (my051 protein). [source:swissprot;acc:q96nk8]\vspace{3pt}}\\\cline{1-1}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
50\vspace{3pt}}&&&&\parbox{\wcE}{\vspace{3pt}\noindent
neurogenic differentiation factor 1 (neurod1) (neurod). [source:swissprot;acc:q13562]\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/